Dose expansion results of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma Meeting Abstract
| Authors: | Hanna, G. J.; Kaczmar, J. M.; Zandberg, D. P.; Wong, D. J. L.; Yilmaz, E.; Sherman, E. J.; Hernando-Calvo, A.; Sacco, A. G.; Chung, C. H.; Bohr, D.; Reiners, R.; Salazar, R.; Gharakhani, E.; Bilic, S.; Muzaffar, J. |
| Abstract Title: | Dose expansion results of the bifunctional EGFR/TGFβ inhibitor BCA101 with pembrolizumab in patients with recurrent, metastatic head and neck squamous cell carcinoma |
| Meeting Title: | 2023 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2023 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-06-01 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.16_suppl.6005 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 6005 -- This meeting was also held virtually -- Source: Cinahl |
